Articles

Morgan Stanley upgrades these two companies as it says Amazon is the best internet stock on ground

The outlook for internet stocks is rosier now that worst-case scenarios of U.S. tariffs on China appear to have been avoided.

Why Trump’s next Fed chair may not deliver the interest-rate cuts investors expect

Trump wants to replace Jerome Powell with a Fed chair who will do what he wants. But that still may not produce the steep cuts Wall Street is counting on.

Is buying a condo a bad idea in this real-estate market?

“‘Why do people talk about them like they’re so evil?”

Trump’s tariffs has made this company, and its investors, happy

Cleveland-Cliffs CEO Lourenco Goncalves said the steelmaker is starting to see the positive impact of President Donald Trump’s tariffs on domestic manufacturing, as it expects increased demand from U.S. automakers.

You’re young, single and rich. Traditional financial planning won’t work for you.

Young people with money are more wary of professional advice.

Verizon’s stock is rising. Here’s the biggest positive from earnings.

Verizon upped its expectations for free cash flow, a closely followed investor metric.

Domino’s stock surges as deliveries are growing again, offsetting an earnings miss

Domino’s stock rallies as a big same-store sales beat and resumption of growth in deliveries offset an earnings miss.

‘Poof! His money could disappear’: My boyfriend is 75. His portfolio is down 4% this year. Do we fire his adviser?

“His portfolio is still down from the April slump when everybody else’s accounts have gone up.”

Palantir, Coinbase and these other volatile stocks are too crowded, says JPMorgan. Here’s the trade to make instead.

The rush into so-called high-beta names is a red-flag for the market, say JPMorgan strategists.

Here’s how much Ryanair staff get paid for identifying oversized cabin bags

Ryanair has a reputation for cost control, and it actually rewards staff for identifying bags that are too big to be carried on board.

Sarepta stock extends decline as company declines FDA call to withdraw drug

Sarepta Therapeutics traded lower on Monday, extending a slide as the company took the unusual step of refusing a Food and Drug Administration request to stop selling a drug tied to three deaths.

‘I have felt invisible, disrespected and heartbroken’: My firstborn son wants nothing to do with me. Do I cut him off?

“My second wife and I agreed that 25% of our total estate would go to my older son, and the remainder to our younger son.”
1 368 369 370 371 372 2,559